Vaxcyte Inc
USUSDVaxcyte Inc (US:PCVX) — Biotechnology: Biological Products (No Diagnostic Substances). Število borz, na katerih se trgujejo delnice družbe: 2. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.
O Podjetju
- Spletna Stran
- vaxcyte.com
- Odnosi z Vlagatelji
- investors.vaxcyte.com/
- Sektor
- Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
- Sedež
- SAN CARLOS, United States
- Izvršni Direktor
- Grant E. Pickering
- Zaposleni
- 507
- Delnice v Obtoku
- 148.81 mio. na dan 2026-08-03
- Prosto Prenosljive Delnice
- 136.44 mio.
- Tržna Kapitalizacija
- 8.34 mrd. USD
- Notranje Osebe
- 0.5%
- Institucionalni Vlagatelji
- 113.47%
- Panoga (SIC)
- Biological Products, (No Diagnostic Substances)
- ISIN
- US92243G1085
- LEI
- 254900M7NMHTGASX8D95
- P/E
- izguba
- FCF
- −894 mio. USD
- Dolg
- ?
- Dobiček in FCF — za 12 mesecev do 30.06.2026 (najnovejše poročilo podjetja).
- NAV
Opis
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria; and VAX-XL, a third-generation pneumococcal conjugate vaccine. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Največji Imetniki
| Imetnik | Delež | Delnice | Datum Poročila |
|---|---|---|---|
| FMR, LLC | 14.01% | 20.85 mio. | 2026-06-30 |
| Jupiter Topco LLC | 12.07% | 17.97 mio. | 2026-06-30 |
| T. Rowe Price Investment… | 8.2% | 12.21 mio. | 2026-06-30 |
| Blackrock Inc. | 8.11% | 12.07 mio. | 2026-06-30 |
| RA Capital Management, L… | 7.71% | 11.47 mio. | 2026-06-30 |
| Wellington Management Gr… | 4.71% | 7 mio. | 2026-06-30 |
| Vanguard Portfolio Manag… | 4.43% | 6.59 mio. | 2026-06-30 |
| Vanguard Capital Managem… | 4.27% | 6.35 mio. | 2026-06-30 |
| State Street Corporation | 3.6% | 5.35 mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.08% | 4.59 mio. | 2026-06-30 |
| Deep Track Capital, Lp | 2.89% | 4.3 mio. | 2026-06-30 |
| T. ROWE PRICE CAPITAL AP… | 2.69% | 4.01 mio. | 2026-06-30 |
| iShares Trust-iShares Ru… | 2.27% | 3.37 mio. | 2026-08-31 |
| VANGUARD INDEX FUNDS-Van… | 2.23% | 3.31 mio. | 2026-06-30 |
| Fidelity Rutland Square… | 2.11% | 3.14 mio. | 2026-07-31 |
| JANUS INVESTMENT FUND-Ja… | 1.8% | 2.68 mio. | 2026-06-30 |
| VANGUARD SPECIALIZED FUN… | 1.57% | 2.34 mio. | 2026-07-31 |
| SPDR SERIES TRUST-State… | 1.55% | 2.31 mio. | 2026-08-31 |
| JANUS INVESTMENT FUND-Ja… | 1.53% | 2.27 mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.28% | 1.91 mio. | 2026-06-30 |
| GUGGENHIME ANDREW (Presi… | ≈0.11% | 167 026 | 2026-08-03 |
| WASSIL JAMES (Chief Oper… | ≈0.1% | 145 435 | 2026-09-09 |
| DHALIWAL HARPREET S. (Of… | ≈0.05% | 76 756 | 2026-08-05 |
| JODAR LUIS (Officer) | ≈0.04% | 52 632 | 2026-09-04 |
| EYDELMAN MIKHAIL (Genera… | ≈0.03% | 41 620 | 2025-03-05 |
| COWAN ELVIA (Officer) | ≈0.02% | 28 975 | 2026-04-07 |
| LUKATCH HEATH SCOTT (Dir… | ≈0.01% | 19 481 | 2026-06-15 |
| LOXAM TERI (Director) | ≈0.01% | 12 481 | 2026-06-15 |
| PAYA CARLOS V (Director) | ≈0.01% | 12 481 | 2026-06-15 |
| PICKERING GRANT E (Chief… | — | — | 2026-07-27 |
Prijavite se z Google